Medtide Inc. (HKG:3880)
Hong Kong · Delayed Price · Currency is HKD 22.44
+0.26 (1.17%)
At close: Mar 27, 2026
Medtide Market Cap
Medtide has a market cap or net worth of 3.18 billion as of March 27, 2026.
Market Cap
3.18B
Enterprise Value
1.99B
Revenue
546.29M
Ranking
n/a
PE Ratio
23.14
Stock Price
22.44
Market Cap Chart
Since June 30, 2025, Medtide's market cap has decreased from 4.37B to 3.18B, a decrease of -27.14%. That is a compound annual growth rate of -34.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 3.18B | -26.38% |
| Dec 31, 2025 | 4.32B | -1.04% |
| Jun 30, 2025 | 4.37B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Qyuns Therapeutics | 4.25B |
| Shandong Boan Biotechnology | 4.18B |
| Viva Biotech Holdings | 4.12B |
| BioDlink International Company | 4.06B |
| TYK Medicines | 3.77B |
| Mirxes Holding Company | 3.71B |
| Clover Biopharmaceuticals | 3.57B |
| AIM Vaccine | 3.50B |